Marker Therapeutics Inc (MRKR) — Strategic Asset Allocation Index
Marker Therapeutics Inc (MRKR) has a Strategic Asset Allocation Index of 107.0% as of March 2023. Strategic assets (PP&E of $17.03 Million plus long-term investments of $-) total $17.03 Million, measured against net assets of $15.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MRKR equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Marker Therapeutics Inc Strategic Asset Allocation Index (2002–2021)
This chart shows how Marker Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2002 to 2021. As of March 2023, the index stands at 107.0%, representing strategic assets of $17.03 Million against net assets of $15.91 Million USD. For live market cap and overall valuation, see Marker Therapeutics Inc (MRKR) total market value.
Annual Strategic Asset Allocation Index for Marker Therapeutics Inc (2002–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Marker Therapeutics Inc from 2002 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Marker Therapeutics Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 50.4% | $22.15 Million | $22.15 Million | $- | $43.99 Million | ▲ +25.5 pp |
| 2020 | 24.8% | $6.79 Million | $6.79 Million | $- | $27.34 Million | ▲ +22.8 pp |
| 2019 | 2.0% | $872.70K | $872.70K | $- | $44.09 Million | ▲ +1.7 pp |
| 2018 | 0.2% | $147.67K | $147.67K | $- | $59.34 Million | ▼ -23.8 pp |
| 2002 | 24.0% | $112.00K | $112.00K | $- | $465.83K | — |